Founded in 2019 and based in New York, SteelSky Ventures invests in high growth companies that improve access, care, and outcomes in women's health across various areas such as medical devices, consumer health, digital health, new healthcare delivery models, ePharmacy, and retail therapeutics. The firm believes that women's healthcare is a global market opportunity that is primed for exponential growth driven by technological and business model innovation, and with $73 million in assets under management and 15+ portfolio companies, SteelSky Ventures is the leading women's health fund.